Human Papilloma Virus Genotype Distribution in Women With Cervical İntraepithelial Neoplasia Mehmet Bülbül1, Berna Dilbaz1, Bilge Aydın Aktürk2, Filiz.

Slides:



Advertisements
Similar presentations
MANAGEMENT OF THE ABNORMAL PAP SMEAR
Advertisements

Evolution of Neoplasia The Uterine Cervix As a Model Raj C. Dash, MD Duke University Medical Center Durham, North Carolina.
COLPOSCOPY RANDOM CERVICAL BIOPSIES ENDOCERVICAL CURETTAGE S.C.P.M.G.-Fontana.
M. Munjoma. Outline Burden of HPV Disease HPV in Zimbabwe HPV Lab Development HPV Protocols.
Cervical Cancer Cervical dysplasia Cervical cancer Causes Risk factors
Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening Obstetrics and Gynecology, Volume 103,
PRE-INVASIVE DISEASE OF THE CERVIX CERVICAL INTRAEPHELIAL NEOPLASIA DR. AMEL AL-SAYED Asst. Prof. & Consultant Ob/Gyne Dept.
CANCER CERVIX A PREVENTABLE CANCER Dr NEETA DHABHAI Sr Consultant. – Gynaecologist Member Expert - Indian Cancer Winners’ Association
Women’s First Health Center Drs. Sylvester, Youngren, Lo and Sansobrino What You Should Know About Cervical Cancer: Part one in a series of four updates.
SoftPAP® A Novel Collection Device for Cervical Cytology.
Screening for cervical cancer. Screening for cervical lesions Common disease Cancer is preventable Screening is easy MUST BE PERFORMED.
In the Name of God. Screening of Cervical Cancer Pap smear and colposcopy F.Behnamfar Gynecology Oncology Fellowship Associate Professor Isfahan University.
Cervical Intraepithelial Neoplasm
Adult Medical-Surgical Nursing
Cervical Cancer. Female Gynecologic Cancers Cervical Cancer.
TEMPLATE DESIGN © Negative LLETZ following severe dyskaryosis: a curious phenomenon Üçyiğit A, Jones M H, Dutta A, El.
2006 ASCCP Consensus Guidelines Anne L. Kittendorf, MD FAAFP Assistant Professor University of Michigan Department of Family Medicine.
HPV-related anogenital cancers
Cervical Cancer: Experiences from a Cohort of HIV-infected Women Pascoe M, Magure T, Mudhokwani P et al Abstract: MOAB0202.
Cytopathology Feb
New Technologies in cervical cancer screening Cosette Wheeler, University of New Mexico Albuquerque, New Mexico.
Chapter 29 Human Papilloma Virus Infection and Immunity.
Cervical Cancer Screening NURS 541: Women’s Healthcare – Diagnosis and Management.
Contact: PRELIMINARY RESULTS OF FIRST HPV PRIMARY SCREENING PRIVATE SECTOR IN BUENOS AIRES FEMALE POPULATION R. Jiménez del Toro,
Discussion & Conclusion
LIQUID-BASED CYTOLOGY AND HPV DNA DETECTION
Public Health England leads the NHS Screening Programmes
Performance of mRNA- and DNA-based high-risk human papillomavirus assays in detection of high-grade cervical lesions ELINA VIRTANEN1, ILKKA KALLIALA2,3,
NEW SCREENING PROTOCOL WITH DUAL-STAINED CYTOLOGY TRIAGE
Trreatment of Preinvasive Lesions
Colposcopic Biopsy Results of HPV 16 and 18 patients in Bartın
Cost-effectiveness Analysis for Cervical Cancer Screening Using HPV DNA Tests in Chile Franco Figueira S, BPharm student1; Cachoeira CV, MD, MBA1; Silva.
CERVIX.
INTRODUCTION: CERVICAL CANCER SCREENING
Clairette RAHARISOLO VOLOLONANTENAINA1 ,
No conflicts of interest
Department of Gynaecology and Obstetrics
2nd UNESCO-Merck Africa Research Summit,
Cervical Cancer in California
Cervical Screening Programme, England, : Graphs
From: Inefficiencies and High-Value Improvements in U. S
Efficacy of random cervical biopsy and routine endocervical curettage in subjects with normal colposcopy.
Risk factors for cervical intraepithelial neoplasia recurrence after loop electrosurgical excision procedure in HIV-1-infected and non-infected women.
CERVICAL SCREENING Public Health England 7th November 2017
Colposcopy triage. Satisfactory colposcopy is defined as complete visualization of the squamocolumnar epithelium, which comprises the cervical region most.
Retest in 12mo with HPV testing
Hoa Nguyen Lam, Huyen Suong Ho Thi et al.
Dr Sam Hibbitts HPV Research Team Obstetrics & Gynaecology
Nasreen Abdullah, MD, MPH
F.Behnamfar Gynecology Oncology Fellow Professor
QUIZ QUESTIONS 1) WHAT ARE THE TWO TYPES OF CERVICAL CANCER?
Prognostic value of human papillomavirus types 16 and 18 DNA physical status in cervical intraepithelial neoplasia  A. Gradíssimo Oliveira, C. Delgado,
Mannose-Binding Lectin Does Not Act as a Biomarker for the Progression of Preinvasive Lesions of Invasive Cervical Cancer Med Princ Pract - DOI: /
Prognostic value of human papillomavirus types 16 and 18 DNA physical status in cervical intraepithelial neoplasia  A. Gradíssimo Oliveira, C. Delgado,
Nat. Rev. Clin. Oncol. doi: /nrclinonc
The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional.
The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional.
SBÜ KAYSERİ ERH Doç. Dr. Gökhan Açmaz
Public Health England leads the NHS Screening Programmes
Cervical Screening for Dysplasia and Cancer in Patients with HIV
Neoplasia of the cervix
What is a Pap smear? A Pap smear (also known as the Pap test) is a medical procedure in which a sample of cells from a woman's cervix (the end of the uterus that.
Cervical excisional treatment of young women: A population-based study
SH-sheikhhasani Gyn-oncologist
Volume 153, Issue 1, Pages (April 2019)
The performance of OncoE6TM cervical test in detecting cervical
Fig. 3. The examinations consumed by the three cervical screening strategies to detect CIN2+/CIN3+. (A) The cases of CIN2+ detected by three current cervical.
Fig. 2. Three cervical screening strategies to detect CIN2+/CIN3+
Oregon HPV Summit - June 2019 Nasreen Abdullah, MD, MPH
Presentation transcript:

Human Papilloma Virus Genotype Distribution in Women With Cervical İntraepithelial Neoplasia Mehmet Bülbül1, Berna Dilbaz1, Bilge Aydın Aktürk2, Filiz Hatipoğlu1, Esra Boyar1 1Adıyaman University Faculty of Medicine, Department of Obstetrics and Gynecology, Adıyaman 2 Adıyaman University Faculty of Medicine, Department of Medical Pathology, Adıyaman

Introduction HPV group causes widespread infection worldwide. Out of 100 genotypes of HPV around 13 are linked with cancers. Of the sexually transmitted 40 HPV genotypes, high-risk strains are mainly HPV16, 18 that cause most of the cervical cancer cases. Other high-risk strains are 31, 33, 45, 52, 58. However there are regional differences about the prevalence of different HPV genotypes.  The aim of this study is to investigate the prevalance of HPV genotypes in patients with cervical intraepithelial neoplasia confirmed by colposcopy-guided biopsies.

Abnormal cervical smear (N=27, 21,1%) Material and Method Adıyaman University Training and Research Hospital Colposcopy Clinic Between April 2015 and March 2017. Colposcopy + Bx N: 128 HPV positive (N=31, 24,2%) Abnormal cervical smear (N=27, 21,1%) Both (N=70, 54,7%)

The pathological findings of the patients with abnormal smear results were as follows: ASCUS (N=46), ASC-H (N=8), LGSIL (N=36), High grade SIL (N=3), Atypical glandular cell (N=3).

Cervical pathologies were confirmed with colposcopy guided- biopsies. 63 patients bening or infectious. 55 patients CIN 1 – CIN 2-3  

Findings Mean±SD Age 41.6±9.6 Gravida 4,6±2,5 Age of first intercourse 19.9±4.6 Out of the 55 patients one patient who was diagnosed to have HG-SIL with cervical smear, was diagnosed to have cervical carcinoma after histopathological analysis of the biopsy specimen taken during colposcopy. 

The most frequently encountered HPV genotype was HPV 16 (42.1%) 54 patients 29 patients CIN1 and 25 patients CIN2-3 The most frequently encountered HPV genotype was HPV 16 (42.1%)

Table 1: The distribution of HPV genotypes in the patient group CIN I 1 (1,9) 8 (14,8) 2 (3,7) 4 (7,4) 3 (5,6) 0 (0,0) CIN II-III 15 (27,8) Total N: 54 23 (42,6) 7 (12,9)

Only one HPV genotype was found in 22 (75 Only one HPV genotype was found in 22 (75.9%) of the patients with CIN I while the remaining had more then one HPV genotype. Out of the 25 patients whose final diagnosis was CIN 2-3, 15 had one HPV genotype (60.0%) while the remaining had at least two HPV genotypes.

Table 2: The presence of HPV genotypes in cervical intraepithelial neoplasias HPV genotypes present 1 >=2 Total CIN I (N=29) 22 (75,9) 7 (24,1) 29 (100) CIN II-III (N=25) 15 (60,0) 10 (40,0) 25 (100) 27 17 54

Discussion As cervical cancer is the one of the leading cause of cancer-related deaths among women worldwide, it is very important to have a nation-wide screening programme for cervical cancer. Previous studies from Turkey reported a prevalence rate of HPV ranging from 1.4% to 26% and the most common HPV types in cytologically abnormal women were HPV 16, HPV 16 and HPV18. Dursun et al reported multiple HPV infection rate in women with normal Pap test as 2.2%. In the presented study multiple infection rate was 35% in patients with hispotahologically confirmed cervical intraepithelial neoplasia (CIN1,2-3).  The presented study points out the importance of colposcopy and colposcopy- guided biopsy in women with abnormal smear or positive HPV testing.

References Tuncer ZS, Basaran M, Ustaçelebi S, Kuzey GM. High-Risk Human Papilloma Virus (HPV) Infection Determined By Hybrid Capture II Assay in a Turkish University Hospital Outpatient Clinic MN-Gorm. 2006. pp. 129–134. Ozçelik B, Serin IS, Gökahmetoğlu S, Başbuğ M, Erez R. Human papillomavirus frequency of women at low risk of developing cervical cancer: a preliminary study from a Turkish university hospital. Eur J Gynaecol Oncol. 2003;24(2):157–9. [PubMed] Seçkin S, Aksoy F, Yıldırım M. Servikal Smearlerde HPV İnfeksiyonu Görülme İndisansı Ankara Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi. 1996;36(1-2-3-4):101–103. Safi Z, Demirezen S, Beksaç MS, Kuzey GM, Kocagöz T, Ustaçelebi Ş, Hasçelik G, Çakar An. İnsan Papilloma Virusunun (IPV) Polimeraz Zincir Reaksiyonu Tekniği İle Servikal Ve Vajinal Akıntı Örneklerinde Saptanması Mn-Klinik Bilimler&Doktor. 2002;8(1):112–114 Dursun P, Senger SS, Arslan H, Kuşçu E, Ayhan A. Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infect Dis. 2009; 9: 191